Evaluation of Lymphatic Vessel Invasion Determined by D2-40 Using Preoperative MRI-Based Radiomics for Invasive Breast Cancer.

[1]  Fei Tong,et al.  Lympho-vascular invasion impacts the prognosis in breast-conserving surgery: a systematic review and meta-analysis , 2022, BMC cancer.

[2]  J. Ren,et al.  Multiparametric MRI-based radiomics nomogram for preoperative prediction of lymphovascular invasion and clinical outcomes in patients with breast invasive ductal carcinoma , 2022, European Radiology.

[3]  B. Koçak,et al.  MRI Radiomics of Breast Cancer: Machine Learning-Based Prediction of Lymphovascular Invasion Status. , 2021, Academic radiology.

[4]  Chencui Huang,et al.  Deep learning radiomic nomogram to predict recurrence in soft tissue sarcoma: a multi-institutional study , 2021, European Radiology.

[5]  J. Park,et al.  Peritumoral edema in breast cancer at preoperative MRI: an interpretative study with histopathological review toward understanding tumor microenvironment , 2021, Scientific Reports.

[6]  Lirong Song,et al.  Intratumoral and Peritumoral Radiomics Based on Functional Parametric Maps from Breast DCE‐MRI for Prediction of HER‐2 and Ki‐67 Status , 2021, Journal of magnetic resonance imaging : JMRI.

[7]  B. Choi.  Dynamic contrast enhanced-MRI and diffusion-weighted image as predictors of lymphovascular invasion in node-negative invasive breast cancer , 2021, World Journal of Surgical Oncology.

[8]  M. Sharbatdaran,et al.  D2-40 A Helpful Marker in Assessment of Lymphatic Vessel Invasion in Carcinoma of Breast , 2020, Iranian journal of pathology.

[9]  Jiabao He,et al.  Intra-tumoural lipid composition and lymphovascular invasion in breast cancer via non-invasive magnetic resonance spectroscopy , 2020, European Radiology.

[10]  G. Torzilli,et al.  Radiomics of Liver Metastases: A Systematic Review , 2020, Cancers.

[11]  F. Gleeson,et al.  Radiomics in predicting treatment response in non-small-cell lung cancer: current status, challenges and future perspectives , 2020, European Radiology.

[12]  C. Burmeister,et al.  Clinicopathological Evaluation of the Potential Anatomic Pathways of Systemic Metastasis from Primary Breast Cancer Suggests an Orderly Spread Through the Regional Lymph Nodes , 2020, Annals of Surgical Oncology.

[13]  Guo-zhao Dai,et al.  Development of a risk-stratification scoring system for predicting lymphovascular invasion in breast cancer , 2020, BMC Cancer.

[14]  W. Long,et al.  Preoperative prediction of lymphovascular invasion in invasive breast cancer with dynamic contrast‐enhanced‐MRI‐based radiomics , 2019, Journal of magnetic resonance imaging : JMRI.

[15]  R. Mann,et al.  Breast MRI: State of the Art. , 2019, Radiology.

[16]  D. Gu,et al.  A Radiomics Nomogram for Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma , 2018, Liver Cancer.

[17]  H. Ojiri,et al.  Breast MRI for prediction of lymphovascular invasion in breast cancer patients with clinically negative axillary lymph nodes. , 2018, European journal of radiology.

[18]  J. Park,et al.  Preoperative MRI features associated with lymphovascular invasion in node‐negative invasive breast cancer: A propensity‐matched analysis , 2017, Journal of magnetic resonance imaging : JMRI.

[19]  S. Edge,et al.  Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual , 2017, CA: a cancer journal for clinicians.

[20]  Eun-Kyung Kim,et al.  Preoperative axillary lymph node evaluation in breast cancer patients by breast magnetic resonance imaging (MRI): Can breast MRI exclude advanced nodal disease? , 2016, European Radiology.

[21]  S. Mugikura,et al.  Peritumoral apparent diffusion coefficients for prediction of lymphovascular invasion in clinically node-negative invasive breast cancer , 2016, European Radiology.

[22]  D. McMillan,et al.  The role of lymphatic and blood vessel invasion in predicting survival and methods of detection in patients with primary operable breast cancer. , 2014, Critical reviews in oncology/hematology.

[23]  D. McMillan,et al.  Immunohistochemical detection improves the prognostic value of lymphatic and blood vessel invasion in primary ductal breast cancer , 2014, BMC Cancer.

[24]  T. Uematsu,et al.  Is lymphovascular invasion degree one of the important factors to predict neoadjuvant chemotherapy efficacy in breast cancer? , 2011, Breast cancer.

[25]  I. Ellis,et al.  Objective assessment of lymphatic and blood vascular invasion in lymph node‐negative breast carcinoma: findings from a large case series with long‐term follow‐up , 2011, The Journal of pathology.

[26]  V. Brouste,et al.  D2-40 in breast cancer: should we detect more vascular emboli? , 2009, Modern Pathology.

[27]  Karel G M Moons,et al.  Meta-analysis of MR imaging in the diagnosis of breast lesions. , 2008, Radiology.

[28]  K. Walgenbach,et al.  Detection of lymphovascular invasion in early breast cancer by D2-40 (podoplanin): a clinically useful predictor for axillary lymph node metastases , 2008, Breast Cancer Research and Treatment.

[29]  M. Rivera,et al.  Issues Relating to Lymphovascular Invasion in Breast Carcinoma , 2006, Advances in anatomic pathology.

[30]  E. van Marck,et al.  Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study , 2006, British Journal of Cancer.

[31]  R W Blamey,et al.  Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma. , 2006, European journal of cancer.

[32]  T. Trikalinos,et al.  Comparison of the diagnostic accuracy of lymphatic endothelium markers: Bayesian approach , 2005, Modern Pathology.

[33]  M. Detmar,et al.  Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. , 2005, The American journal of pathology.

[34]  J. Coindre,et al.  Obvious peritumoral emboli: an elusive prognostic factor reappraised. Multivariate analysis of 1320 node-negative breast cancers. , 1998, European journal of cancer.